Demand Forecast

Drill-down by category, sub-category, or SKU (p50 + p95 model)
Back to category view
Oméga-3 – 500 mg / 120 capsule molle Extrait naturel EPA660 MG+DHA440 MG – Cerveau – Vision – Articulations
SKU · AB0FD5512121122011

Oméga-3 – 500 mg / 120 capsule molle Extrait naturel EPA660 MG+DHA440 MG – Cerveau – Vision – Articulations

longtail 3P MEDICAMENTS
Open on marjanemall.ma

Last 4 weeks demand

26
▼ 18.8% vs prev 4w

Offer Stock

77
Σ Stock across 1 live offer (1P + 3P)

1P stock

0
no 1P (MARJANEMALL) stock in the latest snapshot

Unit price

MAD 101
avg of last 30 sells · latest 2026-10-08

AB0FD5512121122011

History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU. Cutoff: 2026-10-05 · Total forecast: 171 units.
Actual Realistic forecast (p50) Optimistic Out of stock

Price history

Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?

Oméga-3 – 500 mg / 120 capsule molle Extrait naturel EPA660 MG+DHA440 MG – Cerveau – Vision – Articulations · in the longtail cohort · last 4 weeks 26 units, trending down -18.8% · on-hand 77 units

Signals the model saw

  • Cohort: longtail (287 days of history, — units sold over 52 weeks)
  • Volatility (CV): 0.95 — moderate
  • Recent trend: last 4w = 26 units · prev 4w = 32 units
  • Stockouts (last 13 weeks): none — history is reliable
  • Calendar events firing in forecast window: none

Model output

Realistic forecast — next week4.1 units
Realistic forecast — next 4 weeks19.8 units
Realistic forecast — next 3 months53.7 units
Planning level (p75) — next 4 weeks
the order-sizing basis; demand exceeds it ~1 week in 4		24.3 units
Optimistic — next week12.3 units
Optimistic — next 4 weeks (reorder target)48.2 units
Optimistic — next 3 months (quarterly PO target)170.7 units
Legacy μ/wk (reorder pipeline)4.8
Revenue exposure — optimistic, 3 months MAD 17.2K